22nd Century Group Inc (XXII)

[kjgaro]

All of these issues you mention are true for any company that gets regulatory approval. You should go to the "Biotech Values" page on Ihub and see how much a stock can jump after just a P2 or P3 successful trial. Those companies don't generate revenue off of those results alone and still need to be approved. This company has a 325 million market cap. Getting 0.5% of the tobacco market is a 2 billion dollar boost. That is blockbuster status.

There is no need to sell VLN to JUUL. I responded to your previous post about my response from XXII. They can sell them very high nicotine plants and they can just "water (propylene glycol)" it down.

There is no way approval of MRTP is baked into the share price. They will finally start generating revenue and become a growth company. If also gives the FDA ammo to pass the ANPRM since it will become abundantly clear that VLN is readily available and BT has the ability to adopt it now.